Physician profile
Javier Soto
NPI 1104881044
$1,236.47
in general payments reported to CMS, 2019-2025
20 companies · $460 in 2025
The $460 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $47.09 · 2021: $11.72 · 2022: $42.66 · 2023: $221 · 2024: $295 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $653 · Gift: $177 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.55 |
| Gift | $177.33 |
| Education | $146.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $368.26 | 2023-2024 | Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $188.17 | 2024-2025 | |
| Hologic Sales and Service, LLC | $144.72 | 2025 | Fluent Fluid Management System |
| Motiva USA, LLC | $132.93 | 2025 | |
| Organon LLC | $54.74 | 2025 | Nexplanon |
| Novo Nordisk INC | $37.10 | 2024 | Wegovy |
| Nevro Corp. | $35.67 | 2019 | |
| Duchesnay USA Incorporated | $31.02 | 2019 | |
| Mindray Ds USA, INC. | $30.59 | 2021-2022 | |
| Conmed Corporation | $28.36 | 2025 | Airseal |
| Daiichi Sankyo INC. | $23.79 | 2022 | |
| Millicent US INC | $22.40 | 2024 | Intrarosa |
| Lupin INC. | $19.85 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.71 | 2019 | |
| Merck Sharp & Dohme LLC | $19.61 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $19.16 | 2019 | |
| Abbvie INC. | $18.06 | 2019 | |
| Ethicon US, LLC | $15.67 | 2020 | |
| Lilly USA, LLC | $15.09 | 2019 | |
| Exeltis, USA INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.